Document is current
Any future updates will be listed below
-
Authors
Furuya, Chiho
Hashimoto, Yoshinori https://orcid.org/0000-0002-3374-9814
Morishita, Soji https://orcid.org/0000-0003-1081-0130
Inano, Tadaaki
Ochiai, Tomonori https://orcid.org/0000-0001-6156-4211
Shirane, Shuichi
Edahiro, Yoko https://orcid.org/0000-0002-8386-1871
Araki, Marito https://orcid.org/0000-0002-3502-5000
Ando, Miki
Komatsu, Norio https://orcid.org/0000-0003-1880-9126
-
Funding
Funding for this research was provided by:
Japan Society for the Promotion of Science (20H03715)
- License Information
-
More Information
Article History
Accepted: 3 December 2022
First Online: 9 December 2022
Declarations
:
: Araki is an employee of Meiji Seika Pharma and Komatsu has received a salary from PharmaEssentia Japan where he is a board member. All other authors declare no conflicts of interest.
: This study was approved by the Ethics Committee of the School of Medicine, Juntendo University (IRB#M12-0895) and was conducted in accordance with the 1975 Helsinki Declaration.
: Written informed consent was obtained prior to the use of patient samples and the collection of clinical records.
: All authors read the manuscript and agree with its publication in the Journal of Thrombosis and Thrombolysis.
